Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease — Stella

Home/Diabetic Kidney Disease/

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Kidney Disease trials

Trial locations(1 site)

China

Shengjing Hospital, Shenyang, Liaoning

Key details

Sponsor

Shengjing Hospital

Enrollment target

~150 participants

Started

June 2024

Primary completion

June 2027

Age range

18 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.